Cellular Cancer Markers (Contemporary Biomedicine) de Carleton T. Garrett

Cellular Cancer Markers: Contemporary Biomedicine, cartea 12

Carleton T. Garrett

Stewart Sell

In Cellular Cancer Markers leading pathologists and physicians review today's most promising cellular cancer markers, an important emerging class of prognostic markers that can be used in the clinical evaluation of cancer patients. The markers reviewed have been chosen because they are biologically relevant to the growth of cells and possess an accurate and reproducible assay for detection. They also are predictors of tumor behavior, are useful in making clinical decisions, and are cost effective.

Cellular Cancer Markers provides a status report for markers of tumor cell activation, proliferation, and longevity that makes possible an informed judgment regarding the value of many newly proposed tumor markers. It also offers insight into the latest approaches to diagnosing cancer and an appreciation of how these marker-based tests can clarify the prognosis of cancer.

Citește tot Restrânge

	Preț	Express
Paperback (1)	1546^.14 lei 6-8 săpt.
Humana Press Inc. – 17 sep 2011	1546^.14 lei 6-8 săpt.
Hardback (1)	1372^.43 lei 6-8 săpt.
Humana Press Inc. – 3 mar 1995	1372^.43 lei 6-8 săpt.

Preț

Express

Paperback (1)

1546^.14 lei 6-8 săpt.

Humana Press Inc. – 17 sep 2011

1546^.14 lei 6-8 săpt.

Hardback (1)

1372^.43 lei 6-8 săpt.

Humana Press Inc. – 3 mar 1995

1372^.43 lei 6-8 săpt.

Din seria Contemporary Biomedicine

5%

Preț: 1060^.22 lei
5%

Preț: 702^.51 lei
15%

Preț: 631^.40 lei
5%

Preț: 1076^.90 lei
5%

Preț: 1405^.26 lei
5%

Preț: 1380^.87 lei
5%

Preț: 703^.21 lei
5%

Preț: 1376^.44 lei
5%

Preț: 691^.26 lei
18%

Preț: 923^.62 lei
5%

Preț: 702^.84 lei
18%

Preț: 1193^.41 lei
5%

Preț: 690^.73 lei
5%

Preț: 819^.01 lei
8%

Preț: 543^.50 lei
8%

Preț: 580^.15 lei
Preț: 492^.72 lei
Preț: 426^.22 lei
8%

Preț: 582^.73 lei

Cuprins

Ch. 1. Clinical Application of Genetic, Oncogenic, and Differentiation Markers of Cancer.- Ch. 2. ras Proto-Oncogene Activation in Human Malignancy.- Ch. 3. C-myc as a Tumor Marker for Primary Human Cancers.- Ch. 4. p53 in Human Cancer.- Ch. 5. Oncogenes and Tumor-Suppressor Genes in Gynecological Malignancies.- Ch. 6. Genetic Alterations in Colon Cancer.- Ch. 7. Genetic Changes in Breast Cancer.- Ch. 8. Genetic Alterations in Lung Cancer.- Ch. 9. Wilms Tumor-Susceptibility Loci.- Ch. 10. Non-Hodgkin’s Lymphomas.- Ch. 11. Phenotypic Expression of Hodgkin’s Disease: Biologic, Immunologic, and Functional Properties of Reed-Sternberg Cells.- Ch. 12. Melanoma Markers.- Ch. 13. Detection of Minimal Residual Disease (MRD) in Leukemia and Lymphoma.- Ch. 14. P-Glycoproteins in Tumors.- Ch. 15. Genetically Engineered Antitumor Monoclonal Antibodies.- Ch. 16. Targeting Antisense Oligonucleotide Chemotherapy to the Type I Regulatory Subunit of cAMP-Dependent Protein Kinase.- Ch. 17. Summary and Perspective: Assessing Test Effectiveness—The Identification of Good Tumor Markers.